Burning mouth syndrome
Conditions
Interventions
Placebo laser group:The same laser device and operation procedure as the treatment group were used, but the laser was turned off (no energy output), with only indicator lights and sound prompts to ach
6 J/cm2 group:Device: Semiconductor laser therapeutic apparatus (Ceralas, China).
Wavelength and fiber diameter: 810 nm, 400 µm.
Irradiation method: Non-contact (maintaining 1 cm distance), spot a
12J/cm2 group:Device: Semiconductor laser therapeutic apparatus (Ceralas, China).
Wavelength and fiber diameter: 810 nm, 400 µm.
Irradiation method: Non-contact (maintaining 1 cm distance), spot a
18J/cm2 group:Device: Semiconductor laser therapeutic apparatus (Ceralas, China).
Wavelength and fiber diameter: 810 nm, 400 µm.
Irradiation method: Non-contact (maintaining 1 cm distance), spot a
Sponsors
The Affiliated Stomatology Hospital,Kunming Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria for primary burning mouth syndrome as defined by the International Association for the Study of Pain (ICHD-3); 2. Those who have not received any other treatments or medications targeting BMS within the previous 1 month and whose treatment effects were not significant; 3. Informed consent: Understanding the content of this study and voluntarily signing a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Oral burning sensation caused by specific local or systemic diseases such as candidiasis infection, diabetes, vitamin deficiency, Sjögren's syndrome, etc.; 2. Those with a history of photosensitive diseases or allergic to laser treatment; 3. Those with other systemic diseases that may significantly affect the overall oxidative stress level (such as uncontrolled autoimmune diseases, malignant tumors, severe heart, liver and kidney dysfunction, etc.); 4. Those with acute inflammation, ulcers, severe periodontitis or other conditions that may cause local oxidative stress lesions in the oral cavity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the visual analogue scale (VAS) for pain before and after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of the Burning Mouth Syndrome Quality of Life Scale;Saliva flow measurement; | — |
Countries
China
Contacts
Public ContactLiu Yueying;Zhai Jiemie
The Affiliated Stomatology Hospital,Kunming Medical University
Outcome results
None listed